NCT03302494: A trial that was reported late by Coherex Medical
This trial has reported, although it was 18 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03302494 |
|---|---|
| Title | WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2. A Prospective, Multicenter, Randomized, Active Controlled, Clinical Trial of the Coherex WaveCrest® Left Atrial Appendage Occlusion System Compared to the Watchman® LAA Closure Device for the Reduction in Risk of Ischemic Stroke or Systemic Embolism in Subjects With Non-valvular Atrial Fibrillation That Have an Appropriate Rationale to Seek a Non-pharmacologic Alternative to Chronic Oral Anticoagulation. |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 27, 2017 |
| Completion date | Dec. 21, 2023 |
| Required reporting date | Dec. 20, 2024, midnight |
| Actual reporting date | Jan. 8, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 18 |